| Title : SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation - Cohen_2003_J.Pharmacol.Exp.Ther_306_407 |
| Author(s) : Cohen C , Bergis OE , Galli F , Lochead AW , Jegham S , Biton B , Leonardon J , Avenet P , Sgard F , Besnard F , Graham D , Coste A , Oblin A , Curet O , Voltz C , Gardes A , Caille D , Perrault G , George P , Soubrie P , Scatton B |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 306 :407 , 2003 |
| Abstract : Cohen_2003_J.Pharmacol.Exp.Ther_306_407 |
| ESTHER : Cohen_2003_J.Pharmacol.Exp.Ther_306_407 |
| PubMedSearch : Cohen_2003_J.Pharmacol.Exp.Ther_306_407 |
| PubMedID: 12682217 |
Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, Leonardon J, Avenet P, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Voltz C, Gardes A, Caille D, Perrault G, George P, Soubrie P, Scatton B (2003)
SSR591813, a novel selective and partial alpha4beta2 nicotinic receptor agonist with potential as an aid to smoking cessation
Journal of Pharmacology & Experimental Therapeutics
306 :407
Cohen C, Bergis OE, Galli F, Lochead AW, Jegham S, Biton B, Leonardon J, Avenet P, Sgard F, Besnard F, Graham D, Coste A, Oblin A, Curet O, Voltz C, Gardes A, Caille D, Perrault G, George P, Soubrie P, Scatton B (2003)
Journal of Pharmacology & Experimental Therapeutics
306 :407